- Home
- RF vs DGX Comparison
RF vs DGX Comparison
Compare RF & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RF | DGX |
|---|---|---|
| Founded | 1970 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 20.5B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | RF | DGX |
|---|---|---|
| Price | $27.35 | $179.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 15 |
| Target Price | $27.60 | ★ $194.07 |
| AVG Volume (30 Days) | ★ 13.0M | 1.1M |
| Earning Date | 01-16-2026 | 01-29-2026 |
| Dividend Yield | ★ 3.87% | 1.78% |
| EPS Growth | ★ 27.93 | 14.49 |
| EPS | 2.27 | ★ 8.51 |
| Revenue | $6,945,000,000.00 | ★ $10,850,000,000.00 |
| Revenue This Year | $18.34 | $12.37 |
| Revenue Next Year | $4.06 | $3.52 |
| P/E Ratio | ★ $12.06 | $21.07 |
| Revenue Growth | 5.90 | ★ 13.74 |
| 52 Week Low | $17.74 | $148.70 |
| 52 Week High | $27.61 | $197.55 |
Technical Indicators
Market Signals| Indicator | RF | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 75.85 | 39.52 |
| Support Level | $26.17 | $178.61 |
| Resistance Level | $26.63 | $185.12 |
| Average True Range (ATR) | 0.54 | 3.01 |
| MACD | 0.22 | -1.07 |
| Stochastic Oscillator | 96.82 | 6.14 |
Price Performance
Historical ComparisonAbout RF Regions Financial Corporation
Regions Financial is a regional bank based in Alabama, with branches primarily in the Southeastern and Midwestern United States. Regions primarily provides traditional commercial and retail banking and also offers mortgage services, asset management, wealth management, securities brokerage, and trust services.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.